Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study

Hsu C., Dziadziuszko R., Gomez Abreo D. A., Aksoy S., Gil Martin M., Roderburg C., ...More

ANNALS OF ONCOLOGY, 2024 (SCI-Expanded)

• Publication Type: Article / Abstract
• Publication Date: 2024
• Doi Number: 10.1016/j.annonc.2024.05.316
• Journal Name: ANNALS OF ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
• Hacettepe University Affiliated: Yes